Chronic Urticaria Or Hives - Pipeline Review, H2 2011 by GlobalMarketsDirect

VIEWS: 4 PAGES: 42

More Info
									Chronic Urticaria Or Hives – Pipeline Review, H2 2011




  Chronic Urticaria Or Hives - Pipeline Review, H2 2011
                                                                                          Reference Code: GMDHC1241IDB

                                                                                          Publication Date: August 2011




Chronic Urticaria Or Hives – Pipeline Review, H2 2011                                                             GMDHC1241IDB / Pub August 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied
                                                                                                                                         Page(1)
Chronic Urticaria Or Hives – Pipeline Review, H2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                            2
List of Tables                                                                                                               4
List of Figures                                                                                                              5
Introduction                                                                                                                 6
     Global Markets Direct Report Coverage                                                                                   6
Chronic Urticaria Or Hives Overview                                                                                          7
Therapeutics Development                                                                                                     8
     An Overview of Pipeline Products for Chronic Urticaria Or Hives                                                         8
Chronic Urticaria Or Hives Therapeutics under Development by Companies                                                      10
Chronic Urticaria Or Hives Therapeutics under Investigation by Universities/Institutes                                      11
Late Stage Products                                                                                                         12
     Comparative Analysis                                                                                                   12
Mid Clinical Stage Products                                                                                                 13
     Comparative Analysis                                                                                                   13
Early Clinical Stage Products                                                                                               14
     Comparative Analysis                                                                                                   14
Chronic Urticaria Or Hives Therapeutics - Products under Development by Companies                                           15
Chronic Urticaria Or Hives Therapeutics - Products under Investigation by Universities/Institutes                           16
Companies Involved in Chronic Urticaria Or Hives Therapeutics Development                                                   17
     F. Hoffmann-La Roche Ltd.                                                                                              17
     Biofrontera AG                                                                                                         17
     Sun Pharmaceutical Industries Limited                                                                                  18
     FAES Farma SA                                                                                                          18
     JADO Technologies GmbH.                                                                                                19
Chronic Urticaria Or Hives - Therapeutics Assessment                                                                        20
     Assessment by Monotherapy Products                                                                                     20
     Assessment by Combination Products                                                                                     21
     Assessment by Route of Administration                                                                                  22
     Assessment by Molecule Type                                                                                            24
Drug Profiles                                                                                                               26
     BF-derm1 - Drug Profile                                                                                                26
          Product Description                                                                                               26
          Mechanism of Action                                                                                               26
          R&D Progress                                                                                                      26
     Bilastine - Drug Profile                                                                                               28
          Product Description                                                                                               28
          Mechanism of Action                                                                                               28
          R&D Progress                                                                                                      28
     Omalizumab - Drug Profile                                                                                              29
          Product Description                                                                                               29
          Mechanism of Action                                                                                               29
          R&D Progress                                                                                                      29
     Omeprazole + Amoxicillin + Metronidazole - Drug Profile                                                                30
          Product Description                                                                                               30
          Mechanism of Action                                                                                               30
          R&D Progress                                                                                                      30
     Orencia - Drug Profile                                                                                                 31


Chronic Urticaria Or Hives – Pipeline Review, H2 2011                                               GMDHC1241IDB / Pub August 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                     Page(2)
Chronic Urticaria Or Hives – Pipeline Review, H2 2011


          Product Description                                                                                     31
          Mechanism of Action                                                                                     31
          R&D Progress                                                                                            31
     Miltefosine - Drug Profile                                                                                   32
          Product Description                                                                                     32
          Mechanism of Action                                                                                     32
          R&D Progress                                                                                            32
     Methotrexate - Drug Profile                                                                                  33
          Product Description                                                                                     33
          Mechanism of Action                                                                                     33
          R&D Progress                                                                                            33
     Mesalazine - Drug Profile                                                                                    34
          Product Description                                                                                     34
          Mechanism of Action                                                                                     34
          R&D Progress                                                                                            34
     SUN 1334 H - Drug Profile                                                                                    35
          Product Description                                                                                     35
          Mechanism of Action                                                                                     35
          R&D Progress                                                                                            35
     SUN 1334 H - Drug Profile                                                                                    36
          Product Description                                                                                     36
          Mechanism of Action                                                                                     36
          R&D Progress                                                                                            36
     Xolair - Drug Profile                                                                                        37
          Product Description                                                                                     37
          Mechanism of Action                                                                                     37
          R&D Progress                                                                                            37
Chronic Urticaria Or Hives Therapeutics – Drug Profile Updates                                                    39
Chronic Urticaria Or Hives Therapeutics - Discontinued Products                                                   40
Appendix                                                                                                          41
     Methodology                                                                                                  41
          Coverage                                                                                                41
          Secondary Research                                                                                      41
          Primary Research                                                                                        41
          Expert Panel Validation                                                                                 42
     Contact Us                                                                                                   42
     Disclaimer                                                                                                   42




Chronic Urticaria Or Hives – Pipeline Review, H2 2011                                     GMDHC1241IDB / Pub August 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                           Page(3)
Chronic Urticaria Or Hives – Pipeline Review, H2 2011




Lis t o f Ta b le s
Number of Products Under Development for Chronic Urticaria Or Hives, H2 2011                                         8

Products under Development for Chronic Urticaria Or Hives – Comparative Analysis, H2 2011                            9

Number of Products under Development by Companies, H2 2011                                                          10

Number of Products under Investigation by Universities/Institutes, H2 2011                                          11

Comparative Analysis by Late Stage Development, H2 2011                                                             12

Comparative Analysis by Mid Clinical Stage Development, H2 2011                                                     13

Comparative Analysis by Early Clinical Stage Development, H2 2011                                                   14

Products under Development by 
								
To top